<DOC>
	<DOCNO>NCT01482351</DOCNO>
	<brief_summary>The goal research determine power feasibility study design method inform full-scale clinical trial determine whether treatment obstructive sleep apnea old adult mild cognitive impairment delay cognitive decline preserve everyday function .</brief_summary>
	<brief_title>Mild Cognitive Impairment Obstructive Sleep Apnea</brief_title>
	<detailed_description>We collect pilot data 110 participant 1-year outcome treatment obstructive sleep apnea use continuous positive airway pressure validity neuroimaging measure clinical change person mild cognitive impairment obstructive sleep apnea . The result inform study design , sample size , participant recruitment retention method , measure full-scale trial .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<criteria>Inclusion Criteria Participants include study follow criterion meet : Are able provide write informed consent self legally authorize representative . MacArthur Competency Assessment Tool [ MacCATCR ] use assess decision make capacity Moderate severe obstructive sleep apnea ( OSA ) deﬁned apneahypopnea index ( AHI ) &gt; = 15 use either Apnea Risk Evaluation System ( ARES ) OR diagnostic polysomnography screen measure Scoring &lt; = 11 Dementia Severity Rating Scale Scoring educationadjusted total score &lt; 26 Montreal Cognitive Assessment Scoring education adjust score 2835 ( inclusive ) Telephone Interview Cognitive Status Modified Permitted medication stable least 4 week Scoring less equal to14 Beck Depression Inventory II ( BDIII ) 21item scale ( i.e. , nondepressed ) Having study partner , deﬁned informant/caregiver average 10 hour per week contact accompany participant study visit Adequate visual auditory acuity allow test Women must surgically sterile , 2 year postmenopausal Testability willing able complete baseline , 6month , 1year outcome measure , willing send CPAP Smartcard adherence Willing undergo magnetic resonance imaging ( MRI ) provide DNA ApoE4 assessment Completed least 6 grade education good work history inside outside home ( exclude mental retardation ) Fluent English . Exclusion criterion : Patients exclude participate study 1 follow criterion meet : Any signiﬁcant neurologic disease MCI , Parkinson 's Disease , Huntington 's disease , normal pressure hydrocephalus , brain tumor , progressive supranuclear palsy , seizure disorder , subdural hematoma , multiple sclerosis , history signiﬁcant head trauma follow persistent neurologic defect know structural brain abnormality Any MRI exclusion presence pacemaker , aneurysm clip , artiﬁcial heart valve , ear implant , metal fragment foreign object eye , skin , body Psychiatric disorder , include major depression bipolar disorder base DSMIV diagnostic criterion within past 3 month , psychotic feature , agitation behavioral problem within last 3 month could lead difficulty comply protocol , history schizophrenia ( also DSMIV criterion ) History alcohol abuse dependence within past 2 year ( DSMIV criterion ) Any current signiﬁcant systemic illness unstable medical condition could lead difficulty comply protocol ( bronchospasm symptomatic chronic obstructive pulmonary disease indicate regular use bronchodilator , steroid , history carbon dioxide retention , wake hypoxemia , use supplemental oxygen ; uncontrolled thyroid disease , diabetes , seizure disorder ; cirrhosis ; recently diagnose cancer ; clinically signiﬁcant laboratory abnormality B12 ) Any current know condition may increase shortterm risk untreated OSA : symptomatic coronary cerebrovascular disease indicate recent myocardial infarction stroke ( 6 month ) , congestive heart failure ( New York Heart Classiﬁcation stage 3 ) , unstable angina , lifethreatening arrhythmia , cardiomyopathy , transient ischemic attack history drive accident related daytime sleepiness Participating clinical study involve neuropsychological measure conduct twice year another clinical trial Currently receive CPAP bilevel pressure OSA ; Requires oxygen bilevel pressure CPAP titration polysomnography</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>apnea</keyword>
	<keyword>cognition</keyword>
	<keyword>memory</keyword>
	<keyword>function</keyword>
	<keyword>amnestic mild cognitive impairment</keyword>
	<keyword>old adult</keyword>
	<keyword>Alzheimer 's Disease</keyword>
</DOC>